{"id":55154,"date":"2023-12-20T10:12:31","date_gmt":"2023-12-20T10:12:31","guid":{"rendered":"https:\/\/medsname.com\/glyxambi-empagliflozin\/"},"modified":"2026-05-01T10:49:12","modified_gmt":"2026-05-01T10:49:12","slug":"glyxambi-empagliflozin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/glyxambi-empagliflozin\/","title":{"rendered":"Glyxambi (Empagliflozin)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Glyxambi?<\/h3>\n<p style=\"margin:0;\"><strong>Glyxambi<\/strong> je tableta s fixn\u00ed kombinac\u00ed <strong>empagliflozin (inhibitor SGLT-2)<\/strong> a <strong>linagliptin (inhibitor DPP-4)<\/strong> (Empagliflozin 10 nebo 25 mg + Linagliptin 5 mg) se pou\u017e\u00edv\u00e1 k <strong>diabetu 2. typu<\/strong>. Kombinuje dva neinzulinotropn\u00ed mechanismy: empagliflozin zp\u016fsobuje vylu\u010dov\u00e1n\u00ed gluk\u00f3zy ledvinami do mo\u010di (pro glykemick\u00e9, hmotnostn\u00ed, krevn\u00ed tlakov\u00e9, srde\u010dn\u00ed a ren\u00e1ln\u00ed benefity), zat\u00edmco linagliptin zvy\u0161uje hladinu inkretinov\u00fdch hormon\u016f, aby stimuloval gluk\u00f3zo-z\u00e1visl\u00e9 uvol\u0148ov\u00e1n\u00ed inzulinu. O\u010dek\u00e1van\u00e9 sn\u00ed\u017een\u00ed HbA1c: <strong>1,0\u20131,3 bod\u016f<\/strong> \u2014 v\u00edce ne\u017e kter\u00e1koli slo\u017eka samostatn\u011b. O\u010dek\u00e1van\u00fd \u00fabytek hmotnosti: 2\u20133 kg. <strong>Velmi n\u00edzk\u00e9 riziko hypoglyk\u00e9mie<\/strong> p\u0159i samostatn\u00e9m u\u017e\u00edv\u00e1n\u00ed. Jednou denn\u011b, s j\u00eddlem nebo bez. Hlavn\u00ed vedlej\u0161\u00ed \u00fa\u010dinky: genit\u00e1ln\u00ed myk\u00f3za, UTI a vz\u00e1cn\u011b DKA (empagliflozin); vz\u00e1cn\u011b pankreatitida nebo artralgie (linagliptin). Nevhodn\u00e9 pro diabetes 1. typu, DKA, eGFR &lt; 30 a t\u011b\u017ek\u00e9 jatern\u00ed po\u0161kozen\u00ed.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Glyxambi?<\/h2>\n<p>Glyxambi je fixn\u00ed kombinace dvou \u00fa\u010dinn\u00fdch l\u00e1tek v jedn\u00e9 tablet\u011b pro l\u00e9\u010dbu diabetu: <strong>empagliflozin<\/strong> (inhibitor SGLT-2) a <strong>linagliptin<\/strong> (inhibitor DPP-4), v s\u00edle Empagliflozin 10 nebo 25 mg + Linagliptin 5 mg. V\u00fdrobce Boehringer Ingelheim \/ Eli Lilly; dostupn\u00e9 v balen\u00edch po 30, 60, 90 nebo 180 tablet\u00e1ch. P\u0159edepisuje se dosp\u011bl\u00fdm s diabetem 2. typu \u2014 obvykle jako dopln\u011bk k metforminu nebo jako po\u010d\u00e1te\u010dn\u00ed l\u00e9\u010dba u pacient\u016f s v\u00fdraznou hyperglyk\u00e9mi\u00ed, kte\u0159\u00ed by profitovali ze dvou neinzulinotropn\u00edch mechanism\u016f v jedn\u00e9 tablet\u011b.<\/p>\n<h2 class=\"wp-block-heading\">Jak Glyxambi funguje?<\/h2>\n<p>Ob\u011b slo\u017eky p\u016fsob\u00ed na hyperglyk\u00e9mii odd\u011blen\u00fdmi mechanismy \u2014 jeden nez\u00e1visl\u00fd na inzulinu, druh\u00fd zalo\u017een\u00fd na inkretinech:<\/p>\n<ul>\n<li><strong>Empagliflozin<\/strong> blokuje SGLT-2 v proxim\u00e1ln\u00edm tubulu ledvin, co\u017e zp\u016fsobuje vylu\u010dov\u00e1n\u00ed 70\u201390 g gluk\u00f3zy mo\u010d\u00ed denn\u011b. T\u00edm sni\u017euje hladinu gluk\u00f3zy v krvi nez\u00e1visle na inzulinu a tak\u00e9 redukuje v\u00e1hu (2\u20133 kg), krevn\u00ed tlak (3\u20135 mmHg), hospitalizace pro srde\u010dn\u00ed selh\u00e1n\u00ed (studie EMPEROR) a progresi CKD (EMPA-KIDNEY).<\/li>\n<li><strong>Linagliptin<\/strong> blokuje enzym DPP-4, \u010d\u00edm\u017e zvy\u0161uje hladinu inkretinov\u00fdch hormon\u016f GLP-1 a GIP. To stimuluje <em>z\u00e1visl\u00e9 na gluk\u00f3ze<\/em> uvol\u0148ov\u00e1n\u00ed inzulinu a potla\u010duje glukagon \u2014 pouze p\u0159i zv\u00fd\u0161en\u00e9 hladin\u011b gluk\u00f3zy v krvi. Linagliptin je mezi inhibitory DPP-4 unik\u00e1tn\u00ed t\u00edm, \u017ee nevy\u017eaduje \u00fapravu d\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00edm posti\u017een\u00ed.<\/li>\n<\/ul>\n<p>Proto\u017ee \u017e\u00e1dn\u00e1 ze slo\u017eek p\u0159\u00edmo nestimuluje uvol\u0148ov\u00e1n\u00ed inzulinu nez\u00e1visle na gluk\u00f3ze, m\u00e1 Glyxambi <strong>velmi n\u00edzk\u00e9 riziko hypoglyk\u00e9mie<\/strong> p\u0159i samostatn\u00e9m u\u017e\u00edv\u00e1n\u00ed. O\u010dek\u00e1van\u00e9 sn\u00ed\u017een\u00ed HbA1c: <strong>1,0\u20131,3 procentn\u00edho bodu<\/strong> ve srovn\u00e1n\u00ed s jednotliv\u00fdmi slo\u017ekami.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n<p><strong>Obvykl\u00e1 d\u00e1vka:<\/strong> jedna tableta denn\u011b r\u00e1no, s j\u00eddlem nebo bez. Po\u010d\u00e1te\u010dn\u00ed d\u00e1vka z\u00e1vis\u00ed na p\u0159edchoz\u00ed l\u00e9\u010db\u011b a c\u00edlov\u00e9 hladin\u011b glyk\u00e9mie.<\/p>\n<ul>\n<li><strong>Vynechali jste d\u00e1vku?<\/strong> Vezm\u011bte co nejd\u0159\u00edve, pokud si vzpomenete do 12 hodin; jinak vynechejte.<\/li>\n<li><strong>D\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00edm posti\u017een\u00ed:<\/strong> empagliflozin je omezen na eGFR &gt; 20 pro indikace HF\/CKD (&gt; 30 pro glykemickou kontrolu); linagliptin nevy\u017eaduje \u00fapravu d\u00e1vky p\u0159i ren\u00e1ln\u00ed insuficienci. Kombinace se obvykle nedoporu\u010duje p\u0159i eGFR &lt; 30.<\/li>\n<li><strong>Pravidla pro nemocn\u00e9 dny:<\/strong> pauza b\u011bhem akutn\u00edho onemocn\u011bn\u00ed s zvracen\u00edm, pr\u016fjmem nebo sn\u00ed\u017een\u00fdm p\u0159\u00edjmem tekutin (riziko euglykemick\u00e9 DKA a AKI). Obnovte p\u0159i norm\u00e1ln\u00edm p\u0159\u00edjmu potravy a tekutin.<\/li>\n<li><strong>Nezahajovat<\/strong> do 48 hodin po v\u011bt\u0161\u00edm chirurgick\u00e9m z\u00e1kroku nebo pod\u00e1n\u00ed IV kontrastn\u00ed l\u00e1tky.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9 (v\u011bt\u0161inou zp\u016fsoben\u00e9 empagliflozinem):<\/strong><\/p>\n<ul>\n<li>Mykotick\u00e9 infekce genit\u00e1ln\u00ed oblasti (kandid\u00f3za) \u2014 a\u017e u 10 % u\u017eivatel\u016f<\/li>\n<li>Infekce mo\u010dov\u00fdch cest<\/li>\n<li>Polyurie, m\u00edrn\u00e1 dehydratace, ortostatick\u00e9 z\u00e1vrat\u011b v prvn\u00edch 2 t\u00fddnech<\/li>\n<li>M\u00edrn\u00e9 zv\u00fd\u0161en\u00ed LDL-cholesterolu<\/li>\n<\/ul>\n<p><strong>Z linagliptinu:<\/strong><\/p>\n<ul>\n<li>Nazofaryngitida, bolest hlavy, m\u00edrn\u00e9 gastrointestin\u00e1ln\u00ed pot\u00ed\u017ee<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9, ale d\u016fle\u017eit\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Diabetick\u00e1 ketoacid\u00f3za (DKA)<\/strong> \u2014 vz\u00e1cn\u00e9; m\u016f\u017ee se vyskytnout p\u0159i t\u00e9m\u011b\u0159 norm\u00e1ln\u00ed hladin\u011b gluk\u00f3zy v krvi (\u201ceuglykemick\u00e1 DKA\u201d). P\u0159\u00edznaky: nevolnost, zvracen\u00ed, bolesti b\u0159icha, zrychlen\u00e9 d\u00fdch\u00e1n\u00ed. L\u00e9k vysa\u010fte a vyhledejte neodkladnou l\u00e9ka\u0159skou pomoc.<\/li>\n<li><strong>Objemov\u00e1 deplece, akutn\u00ed po\u0161kozen\u00ed ledvin<\/strong> \u2014 vy\u0161\u0161\u00ed riziko p\u0159i u\u017e\u00edv\u00e1n\u00ed diuretik nebo p\u0159i akutn\u00edm onemocn\u011bn\u00ed<\/li>\n<li><strong>Akutn\u00ed pankreatitida, t\u011b\u017ek\u00e1 artralgie, bul\u00f3zn\u00ed pemfigoid<\/strong> \u2014 vz\u00e1cn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky t\u0159\u00eddy DPP-4<\/li>\n<li><strong>Fournierova gangr\u00e9na<\/strong> \u2014 extr\u00e9mn\u011b vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Diuretika (kli\u010dkov\u00e1 a thiazidov\u00e1)<\/strong> \u2014 aditivn\u00ed ztr\u00e1ta objemu; zva\u017ete sn\u00ed\u017een\u00ed d\u00e1vky diuretik.<\/li>\n<li><strong>Inzulin, sulfonylmo\u010doviny, meglitinidy<\/strong> \u2014 aditivn\u00ed sn\u00ed\u017een\u00ed hladiny gluk\u00f3zy; m\u016f\u017ee b\u00fdt nutn\u00e9 sn\u00ed\u017een\u00ed d\u00e1vky, aby se p\u0159ede\u0161lo hypoglyk\u00e9mii.<\/li>\n<li><strong>Rifampicin<\/strong> \u2014 sni\u017euje hladiny obou slo\u017eek.<\/li>\n<li><strong>Antihypertenziva<\/strong> \u2014 aditivn\u00ed sn\u00ed\u017een\u00ed krevn\u00edho tlaku.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kdo by nem\u011bl u\u017e\u00edvat Glyxambi?<\/h2>\n<ul>\n<li>Diabetes mellitus 1. typu<\/li>\n<li>Diabetick\u00e1 ketoacid\u00f3za \u2013 sou\u010dasn\u00e1 nebo ned\u00e1vn\u00e1 anamn\u00e9za<\/li>\n<li>T\u011b\u017ek\u00e9 ren\u00e1ln\u00ed posti\u017een\u00ed (eGFR &lt; 30)<\/li>\n<li>T\u011b\u017ek\u00e1 dehydratace nebo hypotenze<\/li>\n<li>T\u011b\u017ek\u00e9 jatern\u00ed po\u0161kozen\u00ed<\/li>\n<li>Historie pankreatitidy (relativn\u00ed)<\/li>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na kteroukoli slo\u017eku<\/li>\n<li>T\u011bhotenstv\u00ed a kojen\u00ed<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte Glyxambi p\u0159i teplot\u011b do 30 \u00b0C na such\u00e9m m\u00edst\u011b. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Pro\u010d kombinovat inhibitor SGLT-2 a inhibitor DPP-4 v jedn\u00e9 tablet\u011b?<\/h3>\n<p>Tyto dv\u011b t\u0159\u00eddy l\u00e9k\u016f p\u016fsob\u00ed zcela odli\u0161n\u00fdmi mechanismy, kter\u00e9 se nep\u0159ekr\u00fdvaj\u00ed, tak\u017ee sn\u00ed\u017een\u00ed HbA1c u kombinace je aditivn\u00ed (1,0\u20131,3 bod\u016f) sp\u00ed\u0161e ne\u017e redundantn\u00ed. Oba jsou neutr\u00e1ln\u00ed a\u017e p\u0159\u00edzniv\u00e9 v\u016f\u010di hmotnosti a oba maj\u00ed velmi n\u00edzk\u00e9 riziko hypoglyk\u00e9mie, co\u017e z t\u00e9to kombinace \u010din\u00ed vhodnou volbu pro pacienty, kte\u0159\u00ed pot\u0159ebuj\u00ed lep\u0161\u00ed kontrolu glyk\u00e9mie bez p\u0159id\u00e1n\u00ed rizika inzulinu nebo sulfonylmo\u010doviny.<\/p>\n<h3 class=\"wp-block-heading\">Pom\u016f\u017ee mi Glyxambi zhubnout?<\/h3>\n<p>Ano, m\u00edrn\u011b \u2013 typicky 2\u20133 kg za 6\u201312 m\u011bs\u00edc\u016f. \u00dabytek hmotnosti poch\u00e1z\u00ed z empagliflozinov\u00e9 slo\u017eky (vylu\u010dov\u00e1n\u00ed gluk\u00f3zy mo\u010d\u00ed). Linagliptin je v\u016f\u010di hmotnosti neutr\u00e1ln\u00ed.<\/p>\n<h3 class=\"wp-block-heading\">Chr\u00e1n\u00ed Glyxambi m\u00e9 srdce a ledviny?<\/h3>\n<p>Empagliflozinov\u00e1 slo\u017eka m\u00e1 siln\u00e9 d\u016fkazy z klinick\u00fdch studi\u00ed EMPA-REG, EMPEROR-Reduced, EMPEROR-Preserved a EMPA-KIDNEY pro kardiovaskul\u00e1rn\u00ed ochranu, ochranu p\u0159ed srde\u010dn\u00edm selh\u00e1n\u00edm a ochranu ledvin. Linagliptin je v studii CARMELINA kardiovaskul\u00e1rn\u011b neutr\u00e1ln\u00ed. Kombinace tedy zachov\u00e1v\u00e1 kardio-ren\u00e1ln\u00ed v\u00fdhody empagliflozinu.<\/p>\n<h3 class=\"wp-block-heading\">Zp\u016fsob\u00ed Glyxambi n\u00edzkou hladinu cukru v krvi?<\/h3>\n<p>Samotn\u00fd velmi z\u0159\u00eddka. \u017d\u00e1dn\u00e1 ze slo\u017eek nestimuluje uvol\u0148ov\u00e1n\u00ed inzulinu nez\u00e1visle na hladin\u011b gluk\u00f3zy. Hypoglyk\u00e9mie se st\u00e1v\u00e1 probl\u00e9mem, kdy\u017e je Glyxambi kombinov\u00e1n se sulfonylmo\u010dovinou, meglitinidem nebo inzulinem.<\/p>\n<h3 class=\"wp-block-heading\">A co kvasinkov\u00e9 infekce?<\/h3>\n<p>Genit\u00e1ln\u00ed kvasinkov\u00e1 infekce je nej\u010dast\u011bj\u0161\u00edm vedlej\u0161\u00edm \u00fa\u010dinkem (a\u017e u 10 % u\u017eivatel\u016f, v\u011bt\u0161inou \u017een). Obvykle je m\u00edrn\u00e1 a snadno l\u00e9\u010diteln\u00e1. V\u011bt\u0161ina pacient\u016f nemus\u00ed Glyxambi vysadit.<\/p>\n<h3 class=\"wp-block-heading\">Kde si mohu koupit Glyxambi online?<\/h3>\n<p>Glyxambi (Empagliflozin 10 nebo 25 mg + Linagliptin 5 mg) si m\u016f\u017eete objednat na MedsBase v balen\u00edch po 30, 60, 90 nebo 180 tablet\u00e1ch. Dod\u00e1v\u00e1me po cel\u00e9m sv\u011bt\u011b, s diskr\u00e9tn\u00edm balen\u00edm a z\u00e1sobami od ov\u011b\u0159en\u00fdch v\u00fdrobc\u016f s certifikac\u00ed WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed l\u00e9ky na diabetes<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/jardiance-empagliflozin\/\">Jardiance \u2013 monoterapie empagliflozinem<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/trajenta\/\">Trajenta \u2014 monoterapie linagliptinem<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/forxiga-dapagliflozin\/\">Forxiga \u2014 dapagliflozin (alternativa SGLT-2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/januvia\/\">Januvia \u2014 Sitagliptin (DPP-4 alternativa)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/trajenta-duo\/\">Trajenta Duo \u2013 linagliptin + metformin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/glycomet-sr\/\">Glycomet SR \u2014 Metformin s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/diabetes-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na diabetes<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Kombinace s inhibitorem SGLT-2 nesou mal\u00e9, ale z\u00e1va\u017en\u00e9 riziko euglykemick\u00e9 DKA \u2013 v\u017edy u\u017e\u00edvejte pod l\u00e9ka\u0159sk\u00fdm dohledem s dodr\u017eov\u00e1n\u00edm pravidel pro nemoc.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/symbicort-turbohaler\/\">Symbicort Turbohaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/trivastal-la\/\">Trivastal LA<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/lefuheal\/\">Lefuheal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ketanov-injection\/\">Injekce Ketanov<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hydrosar\/\">Hydrosar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reguluje hladinu cukru v krvi<br \/>\n\u2705 Sni\u017euje riziko srde\u010dn\u00edch onemocn\u011bn\u00ed<br \/>\n\u2705 Podporuje <a href=\"https:\/\/medsbase.com\/cs\/rybelsus-an-effective-solution-for-weight-loss\/\" title=\"Rybelsus \u00fa\u010dinn\u00e9 \u0159e\u0161en\u00ed pro hubnut\u00ed\">\u00fabytek hmotnosti<\/a><br \/>\n\u2705 <a href=\"https:\/\/medsbase.com\/cs\/how-to-lower-your-blood-pressure\/\" title=\"Jak sn\u00ed\u017eit krevn\u00ed tlak\">Sni\u017euje krevn\u00ed tlak<\/a><br \/>\n\u2705 Zlep\u0161uje funkci ledvin<\/p>\n<p><span style=\"color: #999999;\">Glyxambi obsahuje empagliflozin a linagliptin<\/span><\/p>","protected":false},"featured_media":55155,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3870,3872,3278],"class_list":{"0":"post-55154","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-empagliflozin","11":"product_tag-glyxambi","12":"product_tag-linagliptin","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/55154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=55154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/55155"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=55154"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=55154"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=55154"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=55154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}